Last reviewed: June 7, 2026 Last updated: June 7, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Additionally, we evaluate and support patients experiencing neurological symptomssuch as numbness, tingling, cognitive changes, or peripheral neuropathywhen a B12 deficiency is suspected or confirmed through laboratory testing
This journey has shaped him into a healthcare professional who values compassion, excellence, growth, and leading with purpose
We also suggested that, as was advocated by the RCGP a week or two earlier, that patients be instructed on how to self-administer their injections
Retatrutide is not a licensed medicine in the United Kingdom
PMC 8716657